News
-
-
-
-
PRESS RELEASE
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies
Wellgistics Health partners with TheracosBio to improve affordability and access to diabetes medication Brenzavvy in the U.S. healthcare system through their maker-to-taker platform and network of 6,500+ pharmacies -
-
-
-
PRESS RELEASE
Wellgistics Health Launches Capital Access Program for 6,500+ Pharmacies and Supply Chain Partners, Unlocking up to $1M in Working Capital
Wellgistics Health partners with RxERP Financial to offer capital access program for pharmacies and wholesalers, enhancing cash flow and supply chain resilience -
-